ABSTRACT
PURPOSE: Occupational and environmental Pb-exposure is associated with protein aggregation diseases which typically present in elderly populations (Parkinsons and cataract). Post-translational processing of crystallins, the major structural proteins of the lens, is altered with short-term Pb-exposure in Fisher 344 rats. In addition, lenses from aged rats become opaque upon long-term exposure to Pb in organ culture. To explore the route to lens opacification in the presence of Pb, cultured lenses from young rats which exhibit higher metabolic activity in lens culture and are more susceptible to experimental cataract in vivo and in vitro were exposed to Pb and evaluated for morphological and biochemical alterations. METHODS: Following culture in Pb (as lead nitrate) for four days (in the presence/absence of oxidative challenge), lenses were examined for clarity, integrity of epithelial layer, and molecular stability including crystallin post-translational modification and choline transport. Clarity of lenses cultured with/without Pb for up to 8 days was assessed to determine if Pb exposure would accelerate opacification. RESULTS: Lenses cultured in Pb for four days exhibited epithelial abnormalities including epithelial cell multilayering and nuclei abnormalities with extension of the nucleated epithelial cells past the bow region. Alterations in crystallin post-translational modifications and decreased membrane transport of choline were noted without corresponding lens opacification or altered α-crystallin chaperone activity. Lenses treated with Pb according to the same exposure protocol with subsequent challenge by hydrogen peroxide became opaque while the contralateral control lenses did not. Lenses which were cultured in the presence of Pb for longer periods with no subsequent oxidative insult exhibited lens failure at earlier time points than did the controls. CONCLUSIONS: These data indicate that Pb-exposure can accelerate the degradation of the cultured lens through induction of epithelial cell abnormalities, induce structural protein modifications before opacity, and predispose the lens to opacification with subsequent oxidant challenge.
Subject(s)
Cataract/chemically induced , Lead/toxicity , Lens, Crystalline/drug effects , Lens, Crystalline/pathology , Nitrates/toxicity , Tissue Culture Techniques , Animals , Biological Transport/drug effects , Cataract/pathology , Electrophoresis, Gel, Two-Dimensional , Epithelium/drug effects , Epithelium/pathology , Eye Proteins/metabolism , Hydrogen Peroxide/pharmacology , Membranes/drug effects , Membranes/metabolism , Oxidation-Reduction/drug effects , Protein Processing, Post-Translational/drug effects , Rats , Rats, Sprague-Dawley , Time Factors , alpha-Crystallins/metabolismSubject(s)
Gram-Positive Bacterial Infections/diagnosis , Nephritis/diagnosis , Nephritis/microbiology , Propionibacterium acnes/isolation & purification , Adult , Diagnosis, Differential , Gram-Positive Bacterial Infections/complications , Gram-Positive Bacterial Infections/pathology , Humans , Male , Nephritis/pathology , PrognosisSubject(s)
Diabetes Mellitus, Type 2/drug therapy , Edema/chemically induced , Heart Failure/chemically induced , Hypoglycemic Agents/adverse effects , Thiazolidinediones/adverse effects , Aged , Blood Volume/drug effects , Edema/physiopathology , Female , Heart Failure/physiopathology , Humans , Kidney/physiology , RosiglitazoneABSTRACT
Both membranous glomerulopathy and acute interstitial nephritis have been reported to occur following treatment with non-steroidal anti-inflammatory drugs. We report the first cases of membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib (Celebrex), a selective COX-2 inhibitor. The rapid and complete resolution of both conditions following discontinuation of Celebrex strongly implicates this agent in disease pathogenesis. These cases enlarge the spectrum of potential renal toxicities of the COX-2-specific non-steroidal anti-inflammatory drugs.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Glomerulonephritis, Membranous/chemically induced , Kidney/pathology , Nephritis, Interstitial/chemically induced , Sulfonamides/adverse effects , Acute Disease , Aged , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Rheumatoid/drug therapy , Celecoxib , Female , Follow-Up Studies , Glomerulonephritis, Membranous/drug therapy , Glucocorticoids/therapeutic use , Humans , Male , Nephritis, Interstitial/drug therapy , Osteoarthritis/drug therapy , Prednisone/therapeutic use , Pyrazoles , Sulfonamides/therapeutic useABSTRACT
We have previously demonstrated that altered exocrine pancreatic stimulus-secretion coupling is associated with ovariectomy and chronic estradiol administration. To elucidate possible mechanisms underlying those effects we examined the ability of chronic administration of different doses of estradiol to regulate the CCK signal transduction pathway in isolated rat pancreatic acini. Doses of estradiol ranging from 0.5 to 119 micrograms/day were administered to ovariectomized rats for 18 days. Ovariectomy was associated with enhanced CCK-stimulated pancreatic amylase release, whereas estradiol dose dependently decreased the magnitude of CCK-stimulated amylase release. Ovariectomy was also associated with enhanced CCK receptor numbers on acinar cell membranes. Estradiol administration was associated with dose-dependent decreases in CCK receptor numbers. Neither ovariectomy nor estradiol administration affected CCK receptor affinity. Moreover, estradiol administration was associated with increased expression of the alpha-subunit of the heterotrimeric G protein Gq/11 (Galphaq/11). Recent findings (H. Ohnishi, S. A. Ernst, D. I. Yule, C. W. Baker, and J. A. Williams. J. Biol. Chem. 272: 16056-16061, 1997) demonstrate that Galphaq/11 may exert a tonic inhibitory effect on pancreatic enzyme release. In view of these findings, the increased expression of Galphaq/11 induced by estradiol likely contributes to the inhibition of pancreatic enzyme release. We conclude that the effect of estradiol to decrease pancreatic secretion is mediated through regulation of CCK receptor density and Galphaq/11 expression.